Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer. - sprookjes - yvandenbroek - TriplyDB

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer.

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer.

http://www.wikidata.org/entity/Q33650639

about

Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47 RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration.Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy?Molecular substratification of bladder cancer: moving towards individualized patient management Multimodal management of muscle-invasive bladder cancer Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors.RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer.Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization Transcriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer.A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment.Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.Más-o-menos: a simple sign averaging method for discrimination in genomic data analysis.Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification.Diagnosis of bladder cancer and prediction of survival by urinary metabolomics Identification of C16orf74 as a marker of progression in primary non-muscle invasive bladder cancer.Matrix metalloproteinase-10 promotes Kras-mediated bronchio-alveolar stem cell expansion and lung cancer formation Differentially expressed genes and interacting pathways in bladder cancer revealed by bioinformatic analysis p63 expression defines a lethal subset of muscle-invasive bladder cancers.Integrated epigenome profiling of repressive histone modifications, DNA methylation and gene expression in normal and malignant urothelial cells.MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer.Evolution of network biomarkers from early to late stage bladder cancer samples.Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A.An Arf-Egr-C/EBPβ pathway linked to ras-induced senescence and cancer.Expression profiling for bladder cancer: strategies to uncover prognostic factors.GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer.Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer Molecular subtyping of bladder cancer using Kohonen self-organizing maps E2F4 regulatory program predicts patient survival prognosis in breast cancer.A four-gene signature predicts disease progression in muscle invasive bladder cancer.Will the 40-gene expression classifier predict responders to EGFR targeted chemotherapy for the invasive bladder cancer patients?Bone marrow mesenchymal stem cells differentiate into urothelial cells and the implications for reconstructing urinary bladder mucosa.A framework to select clinically relevant cancer cell lines for investigation by establishing their molecular similarity with primary human cancers Urothelial cancer gene regulatory networks inferred from large-scale RNAseq, Bead and Oligo gene expression data.Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems An online tool for evaluating diagnostic and prognostic gene expression biomarkers in bladder cancer Assess the expression of ubiquitin specific protease USP2a for bladder cancer diagnosis Three differentiation states risk-stratify bladder cancer into distinct subtypes HER2 as a target in invasive urothelial carcinoma.

P2860

Q24561405-7B321F54-8C24-4F02-B5DC-B6F699939A95 Q24608385-A5718C8D-8F61-4415-9EF4-BDB17E33D671 Q24623746-545FB59A-F5D7-4E08-9EB8-40E365604136 Q26744155-C53DBE9A-31A7-4502-815A-A45120512956 Q26744343-97DCD9DF-DC41-4548-8294-B2301E5C103D Q27011624-01E35208-CAA8-41F3-9C97-7A8A1DFDB75D Q30279180-585B19F4-029C-4589-ABFF-E303C07EC3B2 Q30301104-8DB0B4B2-8117-41E2-83A5-81CB7D45B36C Q30416020-7AC0D1FE-E6E3-41CC-912A-651AE8B0B287 Q30416201-854134D2-3F28-44EB-96AD-A565E65E2CD8 Q30421675-8C735FDB-92A7-44BC-B858-281E482015BC Q30459452-2A0102C3-9807-4EC5-A43C-A61BAB3F2DA2 Q30838620-8610F62F-A973-4CA0-AE82-88974E7A83AA Q33572016-09C0599A-A6CA-44FF-B7F1-40FB03F95EFF Q33628683-8F400E75-6356-474B-AE34-9A98DB496DA5 Q33688951-E3D52463-F2AA-4360-A4F3-F0967287E385 Q33784739-2AB41487-FF25-4145-81D0-2F9A29F8429D Q34056327-954DA353-2AFA-4FF0-926D-DB2E28823481 Q34105197-8259B0CF-299B-4E1A-9C2A-2C3A1D977AFE Q34131185-866A0606-A818-4EC8-8F78-E95BD17A42D0 Q34193379-BDBED6F4-A1CD-452B-A7B6-8C27ED5072D5 Q34227727-F5A6ABE3-41C5-48A3-B972-D571AD3B95FD Q34306779-F0FF9E4D-1A59-407B-9DC5-10337093C017 Q34409699-C48C7D43-0D3D-4BD0-877C-22D2CEF37BC1 Q34455378-9B6B540D-0C06-4E8C-8771-44B58A285CCD Q34537170-118E3052-F372-44C9-BC95-6130D12551D8 Q34539958-FEFF436E-0B5F-4530-A1E2-A5058712A2EB Q34563208-82D845BA-96E5-4682-AF50-BB7D82CE04F8 Q34998489-27655132-93EF-47F8-A906-C5E1CA913EAF Q35000629-03BA7945-4705-483D-BE22-7A060F31438D Q35017006-2B7A3A8C-3C52-4436-8BA5-76F91DF2F2D7 Q35065195-99D7E20E-8761-4C71-9131-E5ABA1D207F0 Q35223703-3138BE25-5A58-408F-A6BF-A4758D4D8BDE Q35624169-A3BA9067-DE28-42ED-B623-721EC5EA560F Q35630898-57C25498-0D7B-4E71-9CA9-FBCD4868F9A8 Q35640830-A5FBB522-99A1-4339-AD90-AAEB7792EAED Q35678922-ADD6A8CB-04EF-4B83-913A-915912F33AC0 Q35739387-BDDEF1D4-C2E9-4EA1-A0C8-907590C3EE57 Q35750975-BADBC417-3A90-443C-8C2F-C9BB7EFC7B79 Q35755382-0B1DF9FE-1E3B-4BED-BC51-E02F41820D01

P2860

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer.

http://www.wikidata.org/entity/Q33650639

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Predictive value of progressio ...... uscle invasive bladder cancer.

@ast

Predictive value of progressio ...... uscle invasive bladder cancer.

@en

type

label

Predictive value of progressio ...... uscle invasive bladder cancer.

@ast

Predictive value of progressio ...... uscle invasive bladder cancer.

@en

prefLabel

Predictive value of progressio ...... uscle invasive bladder cancer.

@ast

Predictive value of progressio ...... uscle invasive bladder cancer.

@en

P1433

Q33650639-F7EA9778-B654-4369-B9DB-D5E48B857DDB

P1476

Q33650639-0EA34DE7-97AC-46AB-9DA3-1E0AC04FA056

P2093

Q33650639-2CB9F76B-AB0D-4078-B95B-53DB2AD33781

Q33650639-2D7CDCF9-54BF-46DC-9CAE-D5AE9967F278

Q33650639-35917E71-4A8F-4A96-A3F3-D6758527A8B7

Q33650639-502AD570-9EE2-4431-B0E3-0087F756B91E

Q33650639-5CD9D1EF-441B-4909-A81A-CC05692AFABB

Q33650639-5EEFAA6F-1E41-4D7B-AA4F-A2796CE9E970

Q33650639-60987F70-1FEB-4E78-B37D-E389983ECE1E

Q33650639-AE005648-65A6-4BAD-A8B5-EF6E30DF05DE

Q33650639-C6BCC22A-CED1-4BA7-9ACD-BF4F1E9837B0

Q33650639-C993CAD3-4BEA-4E7C-8CEF-D4D9F7232BF5

P2860

Q33650639-0B4B57DB-0B00-41EC-AA97-D0F4AD13E73F

Q33650639-14C64B94-A4DF-4803-ABAC-E9C7333032F8

Q33650639-1B3D5491-8C2B-4882-913E-AA03E8535FD7

Q33650639-2EFA49F1-F6DE-4E65-9C7D-0AEFFCDD730C

Q33650639-4895C63B-6013-4ABF-A399-01C1983F0B56

Q33650639-534F5ECB-24C7-4507-B0F2-33BCDD3541C7

Q33650639-53A23F8E-1B4D-4A7B-B6BE-03EA01AEF01E

Q33650639-55216A0F-6088-4949-803F-35070720756A

Q33650639-55BBBFE0-DF0D-4993-916E-C0CE3133711E

Q33650639-5F1C6EAE-48E2-47FB-8045-1E5631D77D4C

P2888

Q33650639-4DD1EADD-6415-448F-B653-72A9CF64958E

P304

Q33650639-D01D3E4A-D18F-4486-815B-B554937CFF80

P31

Q33650639-925612BA-AFF2-4489-B433-A6C5935F6C3E

P356

Q33650639-8D4BCE9F-353D-4C65-B461-C70A2CDE35A3

P478

Q33650639-E33C0E1A-6131-47F8-A117-3466707701C2

P50

Q33650639-B0792AA5-9F0B-4D63-880B-9EEBE8D2849F

P577

Q33650639-1A15F7CD-58FB-4250-862D-F5A020AFA10E

P5875

Q33650639-4B44EC0D-1512-4F85-9345-640AD77DA5A1

P6179

Q33650639-42FB959D-7A52-4F5B-AF3B-774534486538

P698

Q33650639-1EEE3515-073A-4B57-B705-F2F6A6870619

P932

Q33650639-25CAF318-E69D-43CD-8DEA-86F9C11BC9BE

P356

P1433

Molecular Cancer

P1476

Predictive value of progressio ...... uscle invasive bladder cancer.

@en

P2093

Eun-Jong Cha

http://www.w3.org/2001/XMLSchema#string

Eun-Jung Kim

http://www.w3.org/2001/XMLSchema#string

Keon Myung Lee

http://www.w3.org/2001/XMLSchema#string

Min-Ju Kim

http://www.w3.org/2001/XMLSchema#string

Pildu Jeong

http://www.w3.org/2001/XMLSchema#string

Sang-Cheol Lee

http://www.w3.org/2001/XMLSchema#string

Seon-Kyu Kim

http://www.w3.org/2001/XMLSchema#string

Suk-Chul Bae

http://www.w3.org/2001/XMLSchema#string

Sung-Kwon Moon

http://www.w3.org/2001/XMLSchema#string

Wun-Jae Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Cluster analysis and display of genome-wide expression patterns

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

Gene expression profiling predicts clinical outcome of breast cancer

A gene-expression signature as a predictor of survival in breast cancer

Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Gene-expression profiles predict survival of patients with lung adenocarcinoma

High-throughput microarray technologies: from genomics to clinics.

Evolution of von Willebrand factor A (VWA) domains.

P2888

P304

3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-4598-9-3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40897592

http://www.w3.org/2001/XMLSchema#string

P6179

1029197998

http://www.w3.org/2001/XMLSchema#string

P698

20059769

http://www.w3.org/2001/XMLSchema#string

P932

2821358

http://www.w3.org/2001/XMLSchema#string